The Proton Therapy Systems Market to witness digitized complacence between 2016-2024, reaching US$ 2,926.7 Mn

New York, United States, 2022-May-04 — /EPR Network/ —

The Proton Therapy Systems Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.

Growing prevalence of cancer has prompted medical organizations towards development and adoption of advanced treatment procedures, such as proton radiotherapy. The effectiveness of proton therapy continues to gain trust of cancer patients across the globe. The procedure is known for successfully destructing tumor cells by damaging their DNA through a targeted deposition of high-energy radiation dosage onto the tumor.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12358

Furthermore, doctors treating cancer patients are also benefiting from the feasibility of proton therapy as it can be used in conjunction with other treatments. Factors as such continue to promote the adoption of proton therapy for curing cancerous abnormalities. Persistence Market Research projects that by the end of 2024, the global market for proton therapy will bring in more than US$ 2,926.7 Mn in revenues.

Company Profiles

• Hitachi Ltd.
• Ion Beam Applications SA
• Mevion Medical Systems
• Mitsubishi Electric Corporation
• ProNova Solutions, LLC
• ProTom International
• Sumitomo Heavy Industries Ltd.
• Varian Medical Systems

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/12358

In the report, titled “Proton Therapy Market: Global Industry Analysis and Forecast, 2016-2024,” the global market for proton therapy is presently valued at closed to US$ 945 Mn and is projected to soar at a healthy CAGR of 15.2%. The report estimates that governments from all corners of the globe will continue to shore up their healthcare expenditure on cancer care facilities, which will incidentally boost the revenues in global proton therapy market. Additional benefits of availing proton therapy, compared to chemotherapy or radiation therapy, will also instrument a steadfast revenue growth for the market.

Based on a regional analysis compiled in the report, North America is projected to account for a little less than one-third share of global proton therapy revenues throughout the forecast period. However, Europe’s proton therapy market will dominate with close to 38% share and showcase revenue growth at 15.7% CAGR.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/12358

Key highlights of the research report on global proton therapy market follow:

• The market is likely to benefit from companies manufacturing compact set up used in proton beam therapy, which help in saving production costs without impairing product efficacy
• Based on such set ups, multiple-room proton therapy will gain traction by accounting for more than three-fourth of global revenues towards the end of forecast period
• Among multiple cancer indications, the adoption of proton therapy will be relatively higher for treatment of lung cancer, gastro-intestinal cancer, pediatric cancer, head & neck cancer
• Flexible payment options are also boosting the supply of proton therapy devices, while affordability of such devices continues to be a major challenge
• The report also predicts that the demand for proton therapy will be impacted by the therapy’s side-effects which include fatigue, skin irritation, swelling and skin blistering
• Nonetheless, the market will witness opportunistic growth in terms of rising preference to non-invasive treatment of cancerous tumors